Evidence map›Paper›PMID 39595572›Full record

ArticleBiomolecules2024

Fibroblast-Specific Protein-Protein Interactions for Myocardial Fibrosis from MetaCore Network.

Klaus M Frahm, Ekaterina Kotelnikova, Oksana Kunduzova, Dima L Shepelyansky

Abstract read
In one paragraph

Article in Biomolecules, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Klaus M FrahmLaboratoire de Physique Théorique, Université de Toulouse, CNRS, UPS, 31062 Toulouse, France.ORCID 0000-0002-4077-3337
Ekaterina KotelnikovaClarivate Analytics, 08025 Barcelona, Spain.ORCID 0000-0002-8026-078X
Oksana KunduzovaNational Institute of Health and Medical Research (INSERM) U1048, 31432 Toulouse, Cedex 4, France.ORCID 0000-0003-2503-6555
Dima L ShepelyanskyLaboratoire de Physique Théorique, Université de Toulouse, CNRS, UPS, 31062 Toulouse, France.ORCID 0000-0002-2752-0765

Funding

ANR France ANR-17-EURE-0009
6 · The paper itself

Abstract

Myocardial fibrosis is a major pathologic disorder associated with a multitude of cardiovascular diseases (CVD). The pathogenesis is complex and encompasses multiple molecular pathways. Integration of fibrosis-associated genes into the global MetaCore network of protein-protein interactions (PPI) offers opportunities to identify PPI with functional and therapeutic significance. Here, we report the generation of a fibrosis-focused PPI network and identification of fibroblast-specific arbitrators driving reparative and reactive myocardial fibrosis. In TGF-β-mediated fibroblast activation, developed network analysis predicts new regulatory mechanisms for fibrosis-associated genes. We introduce an efficient Erdös barrage approach to suppress activation of a number of fibrosis-associated nodes in order to reverse fibrotic cascades. In the network model each protein node is characterized by an Ising up or down spin corresponding to activated or repairing state acting on other nodes being initially in a neutral state. An asynchronous Monte Carlo process describes fibrosis progression determined by a dominant action of linked proteins. Our results suggest that the constructed Ising Network Fibrosis Interaction model offers network insights into fibrosis mechanisms and can complement future experimental efforts to counteract cardiac fibrosis.

Indexed as

FibroblastsFibrosisMyocardiumProtein Interaction MapsHumansMonte Carlo MethodTransforming Growth Factor betaTransforming Growth Factor betadirected networksfibrosisIsing spinMarkov chainsMonte Carlo methodopinion formationprotein-protein interactions

Identifiers

PMID39595572
PMCPMC11592328

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.